Market Trends of Bio-MEMS Industry
This section covers the major market trends shaping the Bio-MEMS Market according to our research experts:
Microfluidic Chips to Hold the Largest Market Share
- A microfluidic chip is a set of micro-channels etched or molded into a glass, silicon, or polymer materials such as PolyDimethylSiloxane. The chip is usually transparent and its length or width are from 1 cm to 10 cm, and the chip thickness ranges from about 0.5 mm to 5 mm. The micro-channels forming the microfluidic chip are connected together in order to achieve the desired features of mixing, pumping, sorting, or controlling the biochemical environment.
- The microfluidic chips have got traction of applications in the biomedical field as it allows the integration of many medical tests on a single chip. Also, in terms of applications, it features as the cost-effective, easy to manufacture, and easy to use which is driving its adoption rate in the field of healthcare.
- Government entities are also investing extensively in the manufacturing facilities of the microfluidic chips. For instance, in June 2019, NASA invested USD 125,000 as phase-I funding for the project by Techshot to develop in-Space manufacturing of microfluidic chips for use in biological research aboard the International Space Station.
- Also, the researchers are investing in innovating Bio-MEMS for cancer detection in blood. WHO has stated that, one in five men and one in six women worldwide develop cancer during their lifetime, and one in 8 men and one in 11 women die from the disease.
- Moreover, in March 2020, researcher at University of Illinois at Urbana-Champaign found that Graphene-based biosensors could usher in an era of cancer liquid biopsies as graphene is highly sensitive to DNA through its creation of electrical hot spots.
- On the other hand, the increasing demand from the next-generation sequencing application, the microfluidics chips are driving the market for the Bio-MEMS. Currently, there are more than 100 companies indulged in the competitive market fo net-generation sequencing including Illumina Inc and BGI. The applications of the next-generation sequencing are expected to grow significantly in the forecast period, which may create more demand for the microfluidic chips.
North America Region to Grow Significantly
- The North America region is one of the early adaptors to the emerging technologies as may tech companies in the region invest and indulge themselves in commercializing the products in the market. Recently with the ongoing concern about the population health in the United States due to the increasing rate of chronic diseases in the country. According to the Center for Disease Control and Prevention, currently, at least one in six American people are suffering from any of the chronic diseases.
- The companies in the region are extensively investing in the point-of-contact testing applications and self-monitoring devices such as blood glucose testing; because it reduces the cost of healthcare and saves time. Such investments and commercialization of these products are expected to create demand for Bio-MEMS market in the region.
- Moreover, the companies in the region are seeking growth opportunities for the applications of Bio-MEMS by expanding their manufacturing plants which may fuel the demand for the market in North America.
- For instance, Siemens Helathneers recently announced the expansion of its manufacturing facility in Canada. The company has planned to offer wireless solution that enables comprehensive blood analysis testing at the patient’s side on a single room-temperature test card, with results in less than a minute.